Deepak L. Bhatt, MD, MPH: Let me turn now to Dr Navar to discuss what I think is an important part of the discussion. She’s done a lot of work on this. How do we actually estimate patients’ risk for ...

Guidelines emphasize single-pill combinations and deprescribing strategies to combat polypharmacy and hyperpolypharmacy in ...

Read this article to learn how to conduct an advanced cardiovascular assessment to reveal heart abnormalities and associated symptoms and risk factors. Cardiovascular disease remains one of the ...

Before tissue-engineered blood vessels reach the clinic, they must withstand the mechanical stresses of the vascular system—an assessment that is essential, but often expensive. One University of ...

CMS released proposals to update cardiovascular disease risk assessment and risk management services. The organization proposed coding and payment for an atherosclerotic cardiovascular disease risk ...

Please provide your email address to receive an email when new articles are posted on . Peripheral artery disease, or PAD, is a leading cause of lower extremity amputations in the U.S. Health care use ...

Please provide your email address to receive an email when new articles are posted on . Cardiovascular risk-screening and stratification is advised for IBD patients before JAK inhibitor or S1P ...

Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms, changes begin to unfold inside the liver. While hepatic fat accumulation ...

Vascular Access Device Market OverviewThe global vascular access device market is witnessing consistent growth and is ...